glp 1 telehealth The GLP-1 Boom: Innovation or Privacy Nightmare? Start Your Journey with Us
Description
The rising prevalence of type 2 diabetes and obesity in these countries is increasing demand for effective GLP-1 agonist therapies
There are some stipulations
If gastrointestinal symptoms significantly impair quality of life or prevent medication adherence despite conservative management, healthcare providers may consider dose adjustment, alternative agents with potentially different side effect profiles, or referral to a gastroenterologist for specialized evaluation
Furthermore, GLP-1 can amplify insulin signaling in the brain cells, leading to increased insulin sensitivity in the neurons
Multidisciplinary approach: Complex cases may benefit from consultation with pulmonology, cardiology, or other specialists
But, new evidence shows they might also help with depression
